USD 0.58
(34.88%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 | 382.83 Thousand USD | 4.39% |
2023 | 682.4 Thousand USD | -24.05% |
2022 | 898.5 Thousand USD | -10.78% |
2021 | 1 Million USD | 0.0% |
2020 | - USD | 0.0% |
2019 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | -100.0% |
2010 | 187.6 Thousand USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | -100.0% |
2007 | 243 Thousand USD | -51.4% |
2006 | 500 Thousand USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 698.23 Thousand USD | 17.05% |
2024 Q2 | 1.94 Million USD | 353.58% |
2024 Q3 | 1.91 Million USD | -1.53% |
2024 Q4 | 382.83 Thousand USD | -1.79% |
2023 FY | 682.4 Thousand USD | -24.05% |
2023 Q4 | 682.4 Thousand USD | -9.51% |
2023 Q1 | 881.18 Thousand USD | -1.93% |
2023 Q2 | 813.37 Thousand USD | -7.7% |
2023 Q3 | 754.15 Thousand USD | -7.28% |
2022 Q4 | 898.5 Thousand USD | -5.08% |
2022 FY | 898.5 Thousand USD | -10.78% |
2022 Q3 | 946.63 Thousand USD | 3.24% |
2022 Q2 | 916.96 Thousand USD | -4.74% |
2022 Q1 | 962.57 Thousand USD | -4.42% |
2021 Q3 | 416.64 Thousand USD | 0.0% |
2021 FY | 1 Million USD | 0.0% |
2021 Q1 | - USD | 0.0% |
2021 Q4 | 1 Million USD | 141.71% |
2020 FY | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2012 Q1 | - USD | -100.0% |
2012 Q2 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2011 FY | - USD | -100.0% |
2011 Q2 | 189.94 Thousand USD | 1.25% |
2011 Q3 | 804.19 Thousand USD | 323.39% |
2011 Q4 | 17.41 Thousand USD | -97.83% |
2011 Q1 | 187.6 Thousand USD | 0.0% |
2010 FY | 187.6 Thousand USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2008 Q2 | 243 Thousand USD | 0.0% |
2008 Q4 | - USD | -100.0% |
2008 FY | - USD | -100.0% |
2008 Q1 | 243 Thousand USD | -12.59% |
2008 Q3 | 263 Thousand USD | 8.23% |
2007 Q2 | 168 Thousand USD | -66.4% |
2007 Q3 | 263 Thousand USD | 56.55% |
2007 FY | 243 Thousand USD | -51.4% |
2007 Q4 | 278 Thousand USD | 5.7% |
2007 Q1 | 500 Thousand USD | 17.65% |
2006 Q3 | 525 Thousand USD | 5.0% |
2006 Q2 | 500 Thousand USD | 0.0% |
2006 Q4 | 425 Thousand USD | -19.05% |
2006 FY | 500 Thousand USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
American Medical Technologies Inc. | - USD | -Infinity% |
Ansell Limited | 705.27 Million USD | 99.946% |
Ansell Limited | 706.6 Million USD | 99.946% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | 22.41 Million USD | 98.292% |
BioLife Sciences Inc. | - USD | -Infinity% |
CB Scientific, Inc. | - USD | -Infinity% |
Psykey, Inc. | 625 Thousand USD | 38.746% |
ConvaTec Group Plc | 1.22 Billion USD | 99.969% |
ConvaTec Group Plc | 1.22 Billion USD | 99.969% |
Encision Inc. | 67.33 Thousand USD | -468.547% |
Golden Valley Development, Inc | - USD | -Infinity% |
Hear AtLast Holdings, Inc. | - USD | -Infinity% |
LifePoint, Inc. | 151.73 Thousand USD | -152.308% |
Medite Cancer Diagnostics, Inc. | 4.91 Million USD | 92.209% |
Paradigm Medical Industries, Inc. | 615 Thousand USD | 37.75% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | - USD | -Infinity% |
Reflect Scientific, Inc. | 179.96 Thousand USD | -112.731% |
SmileDirectClub, Inc. | 849.37 Million USD | 99.955% |
Sector 10, Inc. | - USD | -Infinity% |
Shandong Weigao Group Medical Polymer Company Limited | 210.77 Million USD | 99.818% |
SheerVision, Inc. | - USD | -Infinity% |
United Health Products, Inc. | 48.48 Thousand USD | -689.534% |
Vasamed, Inc. | 18.95 Thousand USD | -1920.248% |
Wearable Health Solutions, Inc. | 18.46 Thousand USD | -1972.975% |
Yubo International Biotech Limited | 390.44 Thousand USD | 1.949% |